CommentaryRegulation

Biomedical Innovation: A Risky Business at Risk

See allHide authors and affiliations

Science Translational Medicine  17 Aug 2011:
Vol. 3, Issue 96, pp. 96cm23
DOI: 10.1126/scitranslmed.3002459
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article